Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongzhou Lu

Showing results (281-290 of 444) with videos related to

Pageof 45
Sort By:
Frontiers in Immunology|September 19, 2024
Reduced B cell frequencies in cord blood of HIV-exposed uninfected infants: an immunological and transcriptomic analysisYe Jin, Jun Zhao, Tangkai Qi, et al.
Chinese Medical Journal|October 25, 2024
Association between the triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular diseases in people living with human immunodeficiency virus: Evidence from a retrospectively cohort study 2005-2022Liqin Sun, Yinsong Luo, Xinyun Jia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Integrative analysis of swine infectious diseases in the context of xenotransplantationJiayu Li, Kai Liu, Muhammad Ameen Jamal, et al.
Frontiers in Microbiology|February 15, 2019
Gut Microbiota Dysbiosis Is Not Independently Associated With Neurocognitive Impairment in People Living With HIVFengdi Zhang, Junyang Yang, Yongjia Ji, et al.
Frontiers in Immunology|February 20, 2026
Correction: HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strainsTianyang Liu, Xiaowen Li, Xiaolin Yang, et al.
Emerging Microbes & Infections|August 8, 2025
Two-threshold defined immune non-responders are associated with long-term morbidity in people with HIV: a prospective cohort studyXiaorui Li, Liqin Sun, Yun He, et al.
Virology Journal|January 25, 2025
Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialJiangtao Bai, Tetsuya Asakawa, Wenfang Yuan, et al.
The Journal of Infection|June 22, 2024
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variantsXiaohua Gong, Ling Peng, Fuxiang Wang, et al.
Frontiers in Immunology|October 8, 2025
HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strainsTianyang Liu, Xiaowen Li, Xiaolin Yang, et al.
Frontiers in Immunology|June 21, 2021
Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 PatientsZhenyan Wang, Jun Chen, Cuiyun Zhu, et al.
Pageof 45

Showing results (281-290 of 444) with videos related to

Sort By:
Pageof 45
Frontiers in Immunology|September 19, 2024
Reduced B cell frequencies in cord blood of HIV-exposed uninfected infants: an immunological and transcriptomic analysisYe Jin, Jun Zhao, Tangkai Qi, et al.
Chinese Medical Journal|October 25, 2024
Association between the triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular diseases in people living with human immunodeficiency virus: Evidence from a retrospectively cohort study 2005-2022Liqin Sun, Yinsong Luo, Xinyun Jia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Integrative analysis of swine infectious diseases in the context of xenotransplantationJiayu Li, Kai Liu, Muhammad Ameen Jamal, et al.
Frontiers in Microbiology|February 15, 2019
Gut Microbiota Dysbiosis Is Not Independently Associated With Neurocognitive Impairment in People Living With HIVFengdi Zhang, Junyang Yang, Yongjia Ji, et al.
Frontiers in Immunology|February 20, 2026
Correction: HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strainsTianyang Liu, Xiaowen Li, Xiaolin Yang, et al.
Emerging Microbes & Infections|August 8, 2025
Two-threshold defined immune non-responders are associated with long-term morbidity in people with HIV: a prospective cohort studyXiaorui Li, Liqin Sun, Yun He, et al.
Virology Journal|January 25, 2025
Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialJiangtao Bai, Tetsuya Asakawa, Wenfang Yuan, et al.
The Journal of Infection|June 22, 2024
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variantsXiaohua Gong, Ling Peng, Fuxiang Wang, et al.
Frontiers in Immunology|October 8, 2025
HIV subtype-specific gp140-CD4 binding, Temsavir efficacy, and identification of novel adhesion inhibitors against Chinese HIV strainsTianyang Liu, Xiaowen Li, Xiaolin Yang, et al.
Frontiers in Immunology|June 21, 2021
Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 PatientsZhenyan Wang, Jun Chen, Cuiyun Zhu, et al.
Pageof 45